Ligand · VK2
VK2 · 4-[4-[5-[imidazo[1,2-a]pyridin-6-ylmethyl(methyl) amino]-1,3,4-oxadiazol-2-yl]-3-methyl-phenyl]-2,5-dimethyl-pyrazole-3-carbonitrile
VK2, 4-[4-[5-[imidazo[1,2-a]pyridin-6-ylmethyl(methyl) amino]-1,3,4-oxadiazol-2-yl]-3-methyl-phenyl]-2,5-dimethyl-pyrazole-3-carbonitrile (C24 H22 N8 O, 438.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry).…
- Component
- VK2
- Formula
- C24 H22 N8 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
VK2 in 2 structures; the first of them:
- 7OLV · MerTK kinase domain with type 1.5 inhibitor containing a di-methyl, cyano pyrazole group · VK2 A901 · binds VAL601, ALA617, LYS619, MET621, PHE634, GLU637, ALA638, MET641 and 12 more
- 7OLV · Mertk kinase domain with type 1.5 inhibitor containing a di-methyl, cyano pyrazole group · VK2 A901 · binds VAL601, ALA617, PHE634, GLU637, ALA638, MET641, ILE650, LEU652 and 10 more
Residues it binds most
MET 2, ALA 2, PHE 2, VAL 2, LEU 2, ASP 2, GLU 2, ILE 2, PRO 2, LYS 1 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.